Medicare Enrolled
Dr. Bishoy Labib, M.D.
Neurology · Palm Desert, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Labib from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Labib?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Labib
Dr. Bishoy Labib is a neurology specialist in Palm Desert, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Labib performed 2,435 Medicare services across 1,668 unique beneficiaries.
Between the years covered by Open Payments, Dr. Labib received a total of $16,013 from 70 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Labib is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in CA
$16,013 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,435
Medicare services
Top 20% in CA for neurology
1,668
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~128 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,114 | $93 | $500 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
319 | $82 | $250 |
| New patient office visit, complex (60-74 min) | 316 | $163 | $990 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
173 | $375 | $2,500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
129 | $138 | $775 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $65 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
76 | $160 | $4,000 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
57 | $200 | $4,800 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
25 | $70 | $500 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
25 | $104 | $700 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
24 | $70 | $500 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
14 | $33 | $250 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
14 | $90 | $550 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
14 | $108 | $560 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
14 | $9 | $50 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
14 | $39 | $550 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
12 | $36 | $216 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
11 | $222 | $5,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,013
Total received (2018-2024)
Avg $2,288/year across 7 years
Top 18% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,890 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,656
2023
$2,018
2022
$2,528
2021
$2,866
2020
$1,790
2019
$2,156
2018
$1,999
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$257
SK Life Science, Inc.
$244
ACADIA Pharmaceuticals Inc
$213
Eisai Inc.
$174
Alexion Pharmaceuticals, Inc.
$148
Genentech USA, Inc.
$142
Neurocrine Biosciences, Inc.
$141
PFIZER INC.
$132
Amneal Pharmaceuticals LLC
$129
Novo Nordisk Inc
$118
Takeda Pharmaceuticals U.S.A., Inc.
$102
Lilly USA, LLC
$87
Lundbeck LLC
$80
ABBVIE INC.
$75
Abbott Laboratories
$73
CSL Behring
$68
MDD US Operations, LLC
$61
HARMONY BIOSCIENCES LLC
$60
ARGENX US, INC.
$59
Biogen, Inc.
$51
CATALYST PHARMACEUTICALS, INC.
$48
Ipsen Biopharmaceuticals, Inc
$47
GE HEALTHCARE
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$28
Kyowa Kirin, Inc.
$26
Otsuka America Pharmaceutical, Inc.
$26
Boston Scientific Corporation
$25
Top 3 companies account for 26.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,373
Eisai Inc.
$1,270
Alexion Pharmaceuticals, Inc.
$1,090
UCB, Inc.
$869
ACADIA Pharmaceuticals Inc
$768
Lundbeck LLC
$683
Teva Pharmaceuticals USA, Inc.
$678
US WorldMeds, LLC
$613
Amgen Inc.
$588
ABBVIE INC.
$544
Kyowa Kirin, Inc.
$511
Neurocrine Biosciences, Inc.
$494
SK Life Science, Inc.
$344
Amneal Pharmaceuticals LLC
$331
EISAI INC.
$324
Avanir Pharmaceuticals, Inc.
$285
Lilly USA, LLC
$279
CSL Behring
$260
Genentech USA, Inc.
$255
Novartis Pharmaceuticals Corporation
$226
PFIZER INC.
$223
AbbVie Inc.
$221
Akcea Therapeutics, Inc.
$214
Allergan Inc.
$212
MITSUBISHI TANABE PHARMA AMERICA, INC.
$204
Adamas Pharmaceuticals, Inc.
$197
Nevro Corp.
$168
Takeda Pharmaceuticals U.S.A., Inc.
$167
Biohaven Pharmaceuticals, Inc.
$158
ARGENX US, INC.
$156
GENZYME CORPORATION
$144
Abbott Laboratories
$133
Mallinckrodt Hospital Products Inc.
$127
Novo Nordisk Inc
$118
MDD US Operations, LLC
$113
Janssen Pharmaceuticals, Inc
$108
EMD Serono, Inc.
$106
Allergan, Inc.
$106
CATALYST PHARMACEUTICALS, INC.
$103
Ipsen Biopharmaceuticals, Inc
$97
ITF Pharma, Inc.
$89
Neurelis, Inc.
$84
Amylyx Pharmaceuticals, Inc.
$73
Acorda Therapeutics, Inc
$65
HARMONY BIOSCIENCES LLC
$60
AstraZeneca Pharmaceuticals LP
$56
Grifols USA, LLC
$54
Supernus Pharmaceuticals, Inc.
$53
Otsuka America Pharmaceutical, Inc.
$52
Upsher-Smith Laboratories LLC
$49
Corium, LLC
$42
GE HEALTHCARE
$41
Shire North American Group Inc
$40
Avion Pharmaceuticals
$40
Catalyst Pharmaceuticals, Inc.
$38
HOSPIRA, INC.
$34
GE HealthCare
$33
Mitsubishi Tanabe Pharma America, Inc.
$33
Mallinckrodt Enterprises LLC
$31
Sunovion Pharmaceuticals Inc.
$28
Biohaven Pharmaceutical Holding Company Ltd.
$27
Boston Scientific Corporation
$25
TG THERAPEUTICS, INC.
$24
ARBOR PHARMACEUTICALS, INC.
$20
Medtronic USA, Inc.
$15
Celgene Corporation
$15
E.R. Squibb & Sons, L.L.C.
$13
W. L. Gore & Associates, Inc.
$11
Retrophin, Inc.
$9
Travere Therapeutics, Inc.
$1
Top 3 companies account for 23.3% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CARDIOFORM Septal Occluder · COPAXONE · CREXONT · Cholbam · DUOPA · Dhivy · Dysport · EMGALITY · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · LEQEMBI · Leqembi · MAYZENT · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · None · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · Ocrevus · Omnia · Ongentys · PANZYGA · PROCLAIM · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · Repatha · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tiglutik · UBRELVY · ULTOMIRIS · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vumerity · WAKIX · WATCHMAN FLX · Wegovy · XCOPRI · Xadago · ZAVZPRET · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
22
Per 100K population
0.9
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Labib is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Labib experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Labib performed 1,114 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Labib receive payments from pharmaceutical companies?
Yes. Dr. Labib received a total of $16,013 from 70 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Labib's costs compare to other neurologists in Palm Desert?
Dr. Labib's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Labib) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Palm Desert
Browse neurologists in Palm Desert ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology